RecruitingNot ApplicableNCT06536296

The Impact of Music Medicine on Preterm Brain Development and Behavior

The Impact of Music Medicine on Preterm Brain Development and Behavior - A Two-Center Randomized Controlled Trial "The Lullaby Study"


Sponsor

Brigham and Women's Hospital

Enrollment

243 participants

Start Date

May 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators are conducting a two-site randomized control trial with the aim of defining the impact of music (M) without or with parent voice (MPV) on very preterm infants' acute and cumulative stress, intranetwork connectivity on term brain MRI, and language and other neurodevelopmental outcomes at two years corrected age. This is based on the hypothesis that infants in MPV arm are expected to experience the greatest benefit compared with infants receiving standard care.


Eligibility

Min Age: 24 WeeksMax Age: 30 Weeks

Inclusion Criteria2

  • Very preterm infants born between 24+0 and 30+6 weeks' gestational age (GA) from 2 level III NICUs (Brigham and Women's Hospital, Boston, MA and Yale New Haven, CT)
  • Infants who are medically stable per the clinical care team

Exclusion Criteria4

  • Infants with major genetic or congenital anomalies known to be associated with developmental delay
  • Infants with severe brain injury (such as intraparenchymal hemorrhage, severe white matter injury)
  • Infants who are severely ill infants for whom MBI is not feasible
  • Infants of parents who cannot complete questionnaires in English or Spanish.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMusic

Arm 1: Music only

OTHERMusic and parent voice

Arm 2: Music and parent voice

OTHERStandard Care

Standard Care


Locations(2)

Yale New Haven Hospital

New Haven, Connecticut, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06536296


Related Trials